Last updated: September 4, 2024
Sponsor: University of Chicago
Overall Status: Completed
Phase
N/A
Condition
Memory Loss
Speech Disorders
Frontotemporal Dementia
Treatment
Monthly Check-in Session
Clinical Study ID
NCT02439853
IRB23-1336
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Diagnosis of dementia with language as a primary symptom (i.e. aphasia)
An informant who knows the participant well and can answer questions the participant's communication ability
Adequate hearing to follow conversation (correction permitted)
Adequate vision (correction permitted)
Study Design
Total Participants: 57
Treatment Group(s): 1
Primary Treatment: Monthly Check-in Session
Phase:
Study Start date:
March 01, 2013
Estimated Completion Date:
January 31, 2020
Study Description
Connect with a study center
Northwestern University
Chicago, Illinois 60611
United StatesSite Not Available
University of Chicago
Chicago, Illinois 60637
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.